NCT02287597View on ClinicalTrials.gov

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 13, 2014

Primary Completion Date

March 21, 2018

Study Completion Date

March 21, 2018

Conditions

Colorectal Cancer

Trial Locations (4)

10000

Clinical Hospital Centre Zagreb, Zagreb

Uni Hospital For Tumours; Dept of Medical Oncology, Zagreb

21000

Uni Hospital Split; Oncology & Radiotherapy, Split

31000

Clinical Hospital Osijek; Dept For Oncology & Radiotherapy, Osijek

All Listed Sponsors

lead

Hoffmann-La Roche

INDUSTRY

NCT02287597 - An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer: Continued Avastin Plus Chemotherapy After First Progression in Clinical Practice | Biotech Hunter | Biotech Hunter